BioNMR

BioNMR (http://www.bionmr.com/forum/)
-   Journal club (http://www.bionmr.com/forum/journal-club-9/)
-   -   [NMR paper] NMR uncovers direct interaction between human NEDD4-1 and p34(SEI-1). (http://www.bionmr.com/forum/journal-club-9/nmr-uncovers-direct-interaction-between-human-nedd4-1-p34-sei-1-a-24769/)

nmrlearner 07-03-2017 02:31 AM

NMR uncovers direct interaction between human NEDD4-1 and p34(SEI-1).
 
NMR uncovers direct interaction between human NEDD4-1 and p34(SEI-1).

NMR uncovers direct interaction between human NEDD4-1 and p34(SEI-1).

Biochem Biophys Res Commun. 2017 Jun 27;:

Authors: Shrestha P, Yun JH, Ko YJ, Yeon KJ, Kim D, Lee H, Jin DH, Nam KY, Yoo HD, Lee W

Abstract
PTEN, an important tumor suppressor and a key regulator of the PI3K/AKT signaling pathway, is often deleted/mutated in different types of cancer. The E3 ubiquitin ligase NEDD4-1 catalyzes the polyubiquitination of PTEN, thereby acting as a negative regulator of PTEN. Stability of NEDD4-1, in turn, is tightly controlled by a 34*kDa oncoprotein, p34(SEI-1) and it regulates PTEN degradation and activates PI3K/AKT pathway, resulting in cancer metastasis. p34(SEI-1) affects not only the expression of NEDD4-1 during transcription and translation but also the subcellular localization of PTEN. This emphasizes the need to understand, at molecular level, the interaction between NEDD4-1 and p34(SEI-1). A recent study showed that NEDD4-1 interacts with p34(SEI-1) via its WWI domain. However, a detailed interaction for molecular level is yet unknown. We report that the WW1 domain of NEDD4-1 recognizes the SERTA domain containing the proline rich region (PRR motif) in p34(SEI-1). TALOS analysis based on NMR data confirms three conserved ?-sheets in NEDD4-1 WW1 and the central ?-sheet of NEDD4-1 WW1 plays a role for protein stability by the backbone dynamics experiments. NMR titration data revealed the binding site for p34(SEI-1) with NEDD4-1. Our data will provide insights into the molecular mechanism of NEDD4-1 and p34(SEI-1) interaction, which will be directly used for drug design which inhibits the molecular interaction involved in different cancer signaling.


PMID: 28666866 [PubMed - as supplied by publisher]



More...


All times are GMT. The time now is 07:14 AM.

Powered by vBulletin® Version 3.7.3
Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.
Search Engine Friendly URLs by vBSEO 3.6.0
Copyright, BioNMR.com, 2003-2013